2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gynecologic
1
Conditions
Weight Loss
1
Preleukemia
1
Ovarian Neoplasms
1
Osteochondroma
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Nevus, Epithelioid and Spindle Cell
1
Myelodysplastic Syndromes
1
Malnutrition
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioblastoma
1
Giant Cell Tumors
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Carcinoma, Merkel Cell
1
Carcinoma, Lobular
1
Carcinoma in Situ
1
Barrett Esophagus
1
Interventions
Exercise
10
Diet
6
Caloric Restriction
5
Nutrition Assessment
4
Metformin
4
Octreotide
3
Megestrol Acetate
3
Cognitive Behavioral Therapy
3
anamorelin
2
Standard of Care
2
Olanzapine
2
Mirtazapine
2
Melatonin
2
Liraglutide
2
Eicosapentaenoic Acid
2
Diet, Carbohydrate-Restricted
2
Diet Therapy
2
sibutramine
1
remune
1
olanzapine-fluoxetine combination
1
lime
1
irinotecan sucrosofate
1
bermekimab
1
Weight Reduction Programs
1
Urine Specimen Collection
1
Tirzepatide
1
TOPS
1
Surveys and Questionnaires
1
Sugars
1
Sampling Studies
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Weight Loss
×
Sampling Studies
×
Clear all
NCT03027479
2025-12-22
METERMUS-IMC
University Hospital, Tours
Phase NA
Completed
70 enrolled